Nutrition Enhancement Or Support Patents (Class 514/5.5)
-
Publication number: 20140044685Abstract: Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional compositions may provide for retention of lean body mass, which helps to avoid loss of independence and functionality, as well as to improve quality of life especially in the elderly at risk of sarcopenia and frailty. The nutritional compositions include ?-hydroxyisocaproic acid and citrulline. The composition may include other functional ingredients such as, but not limited to whey protein including whey protein micelles, prebiotic fibers, ?-keto-glutarate, eicosapentaenoic acid, L-carnitine, nucleotides, and amino acids. Methods of administering such nutritional products to individuals in need of same are also provided.Type: ApplicationFiled: April 18, 2012Publication date: February 13, 2014Applicant: NESTEC S.A.Inventors: Norman Alan Greenberg, Denis Breuille, Zamzam Kabiry (Fariba) Roughead, Doug Bolster, Jennifer Mager
-
Publication number: 20140037602Abstract: Nutritional compositions for improving, treating and/or preventing various medical conditions and methods of using same are provided. The medical conditions may include allergies, autoimmune diseases, among others. The nutritional compositions include branched chain fatty acids and may include other functional ingredients such as, but not limited to probiotics, nucleotides and amino acids. Methods of administering such nutritional products to individuals in need of same are also provided.Type: ApplicationFiled: April 12, 2012Publication date: February 6, 2014Applicant: NESTEC S.A.Inventors: Doug Bolster, Norman Alan Greenberg, Jennifer Mager, Zamzam Kabiry (Fariba) Roughead
-
Publication number: 20140030241Abstract: Nutritional compositions having dietary nucleotides, ?-3 fatty acids and citrulline are provided. The nutritional compositions may be formulated to improve T cell function, increase arginine availability in vivo, regulate myeloid-derived suppressor cells (“MDSC”), and decrease the risk and/or severity of infection after surgery or trauma. Methods of making, using and administering such nutritional compositions to individuals in need of same are also provided. Methods for modulating the affects of MDSC's are also provided.Type: ApplicationFiled: March 15, 2012Publication date: January 30, 2014Applicant: NESTEC S.A.Inventor: Norman Alan Greenberg
-
Patent number: 8618047Abstract: The invention is directed to liquid enteral nutritional compositions comprising a protein fraction comprising more than 25 weight % and up to 80 weight % of a vegetable protein comprising at least a source of pea protein, and a fat fraction comprising (a) 8 to 15 weight % of linoleic acid; (b) 3.0 to 6.0 weight % of a combination of alpha-linolenic acid, docosahexaenoic acid and eicosapentaenoic acid, wherein the amount of ALA is >2.5 weight % and the combined amount of DHA and EPA is ?2.5 weight %; (c) 10 to 20 weight % of at least one medium-chain fatty acid; and (d) 35 to 79 weight % of at least one mono-unsaturated fatty acid. The compositions provide for a healthy and balanced diet, which is well-tolerated and minimises clinical complications that are frequently associated with the administration of enteral nutrition in patients using tube feeding, especially with respect to a reduced gastric emptying.Type: GrantFiled: July 27, 2012Date of Patent: December 31, 2013Assignee: N.V. NutriciaInventors: Zandrie Hofman, Rogier Daniël van Anholt, Wynette Hermina Agnes Kiers, Marianne Klebach, Marloes Heleen van Beusekom
-
Patent number: 8613918Abstract: A method of utilizing the chymotrypsin level of an individual as a measure of the success of secretin, other neuropeptides, and peptides or digestive enzyme administration to such individuals, and in particular, as a prognosticative of potential secretin, other neuropeptides, peptides, and digestive enzyme administration for persons having ADD, ADHD, Autism and other PDD related disorders.Type: GrantFiled: May 25, 2012Date of Patent: December 24, 2013Assignee: Curemark LLCInventor: Joan M. Fallon
-
Patent number: 8604168Abstract: Medical foods containing glycomacroprotein and additional supplemented amounts of arginine, leucine, and optionally other amino acids, such as tyrosine, are disclosed. The medical foods can be used to provide the complete protein requirements for patients having metabolic disorders such as phenylketonuria.Type: GrantFiled: June 11, 2010Date of Patent: December 10, 2013Assignee: Wisconsin Alumni Research FoundationInventors: Denise M. Ney, Mark R. Etzel
-
Patent number: 8592369Abstract: The present invention relates generally to the field of neuronal health and neuronal protection. One embodiment of the present invention relates to a composition that can be used for the protection of the enteric nervous system from neurodegeneration. Disorders linked to an impaired enteric nervous system can be treated or prevented by the administration of lactoferrin containing compositions according to the present invention.Type: GrantFiled: May 7, 2010Date of Patent: November 26, 2013Assignee: Nestec S.A.Inventors: Magali Faure, Bing Wang, Jeroen Schmitt
-
Patent number: 8586077Abstract: A nutritional composition for infants comprises a protein source, a lipid source and a carbohydrate source wherein the lipid source includes at least 16 wt % linoleic acid and at least 2 wt % ?-linolenic acid expressed as a percentage of total fatty acid content in each case and in amounts such that the ratio of linoleic acid:?-linolenic acid is in the range from 1 to 10.Type: GrantFiled: December 16, 2009Date of Patent: November 19, 2013Assignee: Nestec S.A.Inventors: Catherine Mace, Olivier Kevork Aprikian, Etienne Pouteau
-
Publication number: 20130302448Abstract: A phytin aqueous solution including at least one alpha-hydroxylated carboxylic acid and phytin in a solubilized form, preferably in a concentration ranging from 70 g/L to 270 g/L, and in that it has a pH value ranging from 3 to 5. The phytin aqueous solution may be used in the preparation of a liquid nutritional supplement and in the preparation of a cosmetic composition.Type: ApplicationFiled: May 10, 2012Publication date: November 14, 2013Inventor: Guy PARC
-
Publication number: 20130296233Abstract: The present disclosure provides a dietary supplement that includes plant ferritin; and methods of use of such a supplement.Type: ApplicationFiled: September 7, 2011Publication date: November 7, 2013Applicant: CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLANDInventor: Elizabeth C. Theil
-
Publication number: 20130280239Abstract: The present invention relates to infant/young child nutrition. A set of nutritional compositions having beneficial effects to infants/young children is disclosed. The set of nutritional compositions comprises at least two compositions with varying amounts of components which impart a beneficial effect to the infants young/children. A nutrition kit for infants/young children comprising the set of nutritional compositions is also disclosed as well as a method for manufacturing the set of nutritional components. A dosage regimen is also disclosed.Type: ApplicationFiled: October 25, 2011Publication date: October 24, 2013Applicant: NESTEC S.A.Inventors: Petra Klassen, Corinne Magliola
-
Patent number: 8546325Abstract: It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises a) a lipid fraction comprising at least one of docosahexaneoic acid (DHA), docosapentaenoic acid (DPA) and eicosapentaenoic acid (EPA); b) a protein fraction comprising proteinaceous material from non-human origin which provide at least cysteine and/or taurine; and c) a mineral fraction comprising at least one of manganese and molybdene, the health of these persons improves. Membrane function of several types of mammalian cells improves, which allows efficient treatment of immune related disorders, such as allergy, autoimmune diseases, cancer, cognitive dysfunction and other diseases of the nervous system, neuropathies, such as diabetic neuropathies and neuropathic pains, neuronal damage during insulin resistance, and gut diseases and support of the development of gut and lung function during growth or recovery.Type: GrantFiled: June 20, 2008Date of Patent: October 1, 2013Assignee: N.V. NutriciaInventor: Robert J. J. Hageman
-
Publication number: 20130225486Abstract: The present invention relates to the field of nutrition; in particular to the prevention and/or treatment of malnutrition. One embodiment of the present invention relates to a nutritional composition enriched in cysteine for use in the treatment and/or prevention of malnutrition and disorders related thereto. Such a composition may in particular, but not exclusively, be useful for the elderly population.Type: ApplicationFiled: October 19, 2011Publication date: August 29, 2013Inventors: Denis Breuille, Isabelle Papet, Karine Vidal
-
Publication number: 20130216521Abstract: A dietary supplement system including three general components is provided. The first component is the fatty acid component and this includes sunflower seeds (containing omega 6 fatty acids), flax seed (containing omega 3 fatty acids) and powdered oils (containing omega 3 or omega 6 fatty acids and generally produced from sunflower oils). The weight ratio of omega 6 fatty acids to omega 3 fatty acids is 10:1 to 1:1, with 10:1 to 5:1 being preferred for normal animals and 2:1 to 1:1 being preferred for animals which have fatty acid responsive conditions. The second component is the GI component, which is used for facilitating animal gut health. This component includes prebiotics, probiotics and immunoglobulin (typically from albumin concentrate). The third component is the breed specific component and can include vitamins, minerals, additional fatty acids, antioxidants, amino acids, palatants, and nutraceutical additives.Type: ApplicationFiled: February 3, 2012Publication date: August 22, 2013Inventors: Melinda Fernyhough Culver, Alison Weber, Marta Draper, Tom Myers
-
Publication number: 20130210714Abstract: A composition comprising at least partially defatted meal from a plant source containing protein-bound tryptophan, which plant source has been processed to at least partially remove oil contained therein to yield said meal having a natural source of tryptophan greater than its plant source, a carbohydrate source having a high glycemic index and a physiologically-acceptable diluent or carrier therefor for inducing sleep, alleviating an anxiety disorder, depression, obsessive compulsive aggression, chronic pain or eating disorder, in a human in need thereof, wherein said composition is in the form of a food bar further comprising a puffed cereal. The composition provides improved sleep characteristics.Type: ApplicationFiled: August 17, 2011Publication date: August 15, 2013Inventors: Susan P. Hudson, Craig Hudson
-
Publication number: 20130209373Abstract: Nutritional compositions that mimic whole foods and methods of using the nutritional compositions are provided. The nutritional compositions may include an increased number and variety of fruits and vegetables, an increased variety of macronutrient sources and an increased amount of other components that are found in whole foods. The nutritional compositions may also include ethnicity-specific meals and organic ingredients and provide emotional appeal to the patient and/or the patient's caregiver.Type: ApplicationFiled: June 28, 2011Publication date: August 15, 2013Applicant: NESTEC S.A.Inventors: Jennifer Mager, Zamzam Fariba Roughead, Heidi Storm, James Scott Teresi
-
Publication number: 20130203664Abstract: Nutritional compositions having reduced amounts of calories and high amounts of protein and methods of making and using the nutritional compositions are provided. The nutritional compositions may include a processed whole food component, a high amount of protein, and a reduced amount of calories in order to provide a patient with a pH-balanced formulation that includes the benefits of food bioactives beyond essential macro- and micronutrients without providing excessive energy. Methods of administering such nutritional compositions to patients in need of improved bone, muscle, neurological, immune, and/or overall health are also provided.Type: ApplicationFiled: June 28, 2011Publication date: August 8, 2013Applicant: NESTEC S.A.Inventors: Doug Bolster, Zamzam Fariba Roughead, Norman Alan Greenberg, Jennifer Mager
-
Publication number: 20130203663Abstract: Nutritional compositions that mimic whole foods and methods of using the nutritional compositions are provided. The nutritional compositions may include an increased number and variety of fruits and vegetables, an increased variety of macronutrient sources and an increased amount of other components that are found in whole foods. The nutritional compositions may also include ethnicity-specific meals and organic ingredients and provide emotional appeal to the patient and/or the patient's caregiver. Methods of administering such nutritional compositions to patients in need of same are also provided.Type: ApplicationFiled: June 28, 2011Publication date: August 8, 2013Applicant: NESTEC S.A.Inventors: Jennifer Mager, Zamzam Fariba Roughead, Heidi Storm, James Scott Teresi
-
Publication number: 20130202637Abstract: A dietary supplement containing a source of ellagic acid, such as black raspberry seed powder, is combined with one or more of blue green algae, brown seaweed, phycocyanin and phenylathylemine. Additions of one or more vitamins and/or one or more minerals further improves the health enhancing benefits of the dietary supplement.Type: ApplicationFiled: February 2, 2013Publication date: August 8, 2013Inventor: John V. Cappello
-
Patent number: 8497238Abstract: It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises: a) a lipid fraction comprising at least one of docosahexaneoic acid (DHA), docosapentaenoic acid (DPA) and eicosapentaenoic acid (EPA); b) a protein fraction comprising proteinaceous material from non-human origin which provide at least cysteine and/or taurine; and c) a mineral fraction comprising at least one of manganese and molybdene, the health of these persons improves. Membrane function of several types of mammalian cells improves, which allows efficient treatment of immune related disorders, such as allergy, autoimmune diseases, cancer, cognitive dysfunction and other diseases of the nervous system, neuropathies, such as diabetic neuropathies and neuropathic pains, neuronal damage during insulin resistance, and gut diseases and support of the development of gut and lung function during growth or recovery.Type: GrantFiled: June 20, 2008Date of Patent: July 30, 2013Assignee: N.V. NutriciaInventors: Robert Johan Joseph Hageman, Mattheus Cornelis De Wilde, Patrick Joseph Gerardus Hendrikus Kamphuis
-
Publication number: 20130189330Abstract: Provided is an enteral nutrient which, although containing a soy protein as a protein source, does not cause a rapid increase in viscosity and inhomogeneity due to aggregation or thermal denaturation by heating for sterilization or formulation step and is thus stable, and shows a good taste without giving any sense of bitterness and coarseness on the throat inherent to soybean. The enteral nutrient is an enteral nutrient of acidic type which comprises a protein, a fat, a carbohydrate, a vitamin, a mineral and a food fiber and has a pH of 3.0 to 4.5, wherein a soy protein containing 20 to 40% of a peptide fraction having a molecular weight of less than 6000 is formulated in an amount of 5 to 65% of the total protein.Type: ApplicationFiled: September 29, 2011Publication date: July 25, 2013Applicant: Terumo Kabushiki KaishaInventors: Yasuyo Tani, Tsuyoshi Ariizumi
-
Patent number: 8486888Abstract: The invention provides an orally-administrable nutritional product comprising a dipeptide including a branched chain amino acids (BCAA). In one embodiment, the nutritional product comprises a dipeptide selected from at least one of the following: alanyl-leucine, alanyl-isoleucine, alanyl-valine, glycyl-leucine, glycyl-isoleucine, and glycyl-valine.Type: GrantFiled: October 8, 2010Date of Patent: July 16, 2013Assignee: Nestec S.A.Inventor: Norman Alan Greenberg
-
Publication number: 20130172245Abstract: Provided is a liquid food composition capable of semi-solidifying in the stomach, which is a one-pack type product containing a water-soluble dietary fiber preliminarily added thereto and in the form of a liquid that can be easily taken, and stably sustains the liquid nature thereof during distribution and storage. The liquid food composition, which is capable of semi-solidifying in an acidic region, comprises a water-soluble dietary fiber (a), a specific metal compound (b), a protein (c) and an emulsifier (d), and the particle size distribution of particles contained in said liquid food composition shows two or more peaks in a neutral region.Type: ApplicationFiled: December 17, 2010Publication date: July 4, 2013Applicant: KANEKA CORPORATIONInventors: Hiroaki Inoue, Yui Kawashima, Kazuya Hamada, Shinichi Yokota, Hiromi Maeda, Tatsumasa Mae, Jun Tomono
-
Publication number: 20130130972Abstract: The present invention relates to the field of nutritional compositions. In particular, the present invention relates to a nutritional composition comprising sugar substitutes and to their use, e.g., to increase exogenous carbohydrate oxidation, which has been shown to increase performance, for example the performance of athletes.Type: ApplicationFiled: March 14, 2011Publication date: May 23, 2013Inventors: Johannes Le Coutre, Peter Van Bladeren, Sami Damak, Trent Stellingwerff
-
Patent number: 8445026Abstract: Novel methods for biological effective, stable amorphous and monoclinic selenium nanoparticles are disclosed. They are prepared by reacting selenium source with a reducing agent or an oxidative agent in an aqueous media at a temperature between 0-100° C. in the presence of selenium binding polymer molecules such as poly/oligopeptide acids or peptone or nucleic acids or poly/oligosaccharide or their mixtures.Type: GrantFiled: November 21, 2008Date of Patent: May 21, 2013Inventors: Xueyun Gao, Yi Sun
-
Publication number: 20130108605Abstract: A method of supplementing a diet and ameliorating oxidative stress in a mammal includes administering a pharmaceutically effective amount of lipid soluble, hydrophobic active compounds having a chemical structure: wherein R1 is an aromatic backbone and R2 is a sulfur containing ligand. Through formation of disulfide linkages other moieties can be attached to R2 converting the hydrophobic base into a water soluble entity, for ease of delivery, which can be reconverted back to the original compound by biochemical reduction in the blood stream.Type: ApplicationFiled: December 17, 2012Publication date: May 2, 2013Applicant: THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATIONInventor: THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
-
Publication number: 20130095189Abstract: The present disclosure relates methods of promoting phase II enzyme gene expression in a pediatric subject, comprising administering to the subject a nutritional composition comprising an effective amount of a phytonutrient. The disclosure also relates to methods of promoting phase II enzyme gene expression in a prenatal infant, comprising administering to a female pregnant with the prenatal infant an effective amount of a composition comprising phytonutrients. The disclosure further relates to a method of promoting phase II enzyme gene expression in a prenatal infant, comprising administering to a female pregnant with the prenatal infant an effective amount of a composition comprising phytonutrients.Type: ApplicationFiled: October 14, 2011Publication date: April 18, 2013Inventors: Zeina Jouni, Bryan Hanley, Aedin Cassidy
-
Patent number: 8409840Abstract: The present invention pertains in general to Bromelain and particularly to the different active compounds contained in this complex mixture of proteins. The present invention provides recombinant expressed cysteine proteases, which are found in Bromelain. It has been found that the method for expression of the recombinant proteins is superior to the purification from Bromelain itself.Type: GrantFiled: August 8, 2008Date of Patent: April 2, 2013Assignee: Ursapharm Arzneimittel GmbHInventors: Rolf Müller, Nora Luniak, Klaus Eschmann
-
Publication number: 20130079276Abstract: The present invention concerns an improved balance of the essential branched chain amino acids leucine, isoleucine and valine in infant formula.Type: ApplicationFiled: March 25, 2011Publication date: March 28, 2013Inventors: Johannes Bernard Van Goudoever, Eline Marleen Van Der Beek, Marieke Abrahamse-Berkeveld, Günther Boehm
-
Patent number: 8377876Abstract: The present invention relates to an amino acid solution for the parenteral nutrition of pediatric patients. The amino acid solution provides for an increased concentration of glutamine, tyrosine, cysteine and taurine, while the concentrations of phenylalanine and methionine is small. Glutamine and tyrosine are provided in the form of oligopeptides.Type: GrantFiled: March 5, 2007Date of Patent: February 19, 2013Assignee: Fresenius Kabi Deutschland GmbHInventors: Ortrud Brand, Thorsten Erbe, Georg Achleitner, Norbert Feichtinger
-
Publication number: 20130029905Abstract: The present invention relates to a formulation containing curcuminoids exhibiting enhanced in vivo bioavailability and resultant improved efficacy, said formulation comprising curcuminoids and a gel forming, non digestive and soluble dietary polysaccharide fiber galactomannan and proteins derived from fenugreek [Trigonella Foenum graecum]. The invention also relates to a process for producing the said formulation and extracting non-digestible soluble dietary polysaccharide fiber galacomannans containing proteins from fenugreek seeds.Type: ApplicationFiled: January 27, 2012Publication date: January 31, 2013Applicant: M/S Akay Flavours & Aromatics Pvt LtdInventors: Krishnakumar Illathu Madhavamenon, Abhilas Ravi, Dinesh Kumar, Balu Paulose Maliakel
-
Publication number: 20130020226Abstract: The invention relates to a high-amino-acid, low-lipid and low-carbohydrate parenteral nutrition solution for administration to obese intensive-care patients, and to a three-chamber pouch which comprises the amino acid component, the carbohydrate component and the lipid component of the parenteral nutrition solution separately in three different chambers.Type: ApplicationFiled: July 20, 2012Publication date: January 24, 2013Applicant: Fresenius Kabi Deutschland GmbHInventors: Rosa Abele, Ewald Schlotzer
-
Patent number: 8343531Abstract: The invention provides a composition used for promoting glucose uptake, which comprises a peptide having an effect of promoting glucose uptake as the active ingredient, as well as a composition comprising a dipeptide containing leucine and/or isoleucine as the active ingredient. The composition is effective in preventing or treating diabetes mellitus or an elevation of blood glucose level, in promoting glycogen storage, or in enhancing physical strength, enhancing athletic ability, improving endurance performance or relieving fatigue.Type: GrantFiled: April 20, 2007Date of Patent: January 1, 2013Assignee: Meiji Co., Ltd.Inventors: Masashi Morifuji, Keiko Kurashige, Chiaki Sanbongi
-
Publication number: 20120328585Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.Type: ApplicationFiled: September 4, 2012Publication date: December 27, 2012Inventors: Bryon W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
-
Patent number: 8329646Abstract: The invention provides methods for treating muscle loss in an individual. In one embodiment, the invention includes administering to an individual an effective amount of a branched chain amino acid (BCAA), a BCAA precursor, a BCAA metabolite, a BCAA-rich protein, a protein manipulated to enrich the BCAA content or any combination thereof. The invention further provides nutritional products for such administration, including orally-administrable nutritional products.Type: GrantFiled: November 28, 2006Date of Patent: December 11, 2012Assignee: Nestec S.A.Inventors: Michael John Tisdale, Norman Alan Greenberg, Helen Laura Eley, Kevin Burke Miller
-
Publication number: 20120308525Abstract: Nutritional compositions and methods of making and using the nutritional compositions are provided. In a general embodiment, the present disclosure provides a nutritional composition including a high protein component and one or more exogenous nucleotides. The nutritional compositions can be specifically used to accelerate and improve wound healing in a mammal.Type: ApplicationFiled: November 19, 2010Publication date: December 6, 2012Applicant: NESTEC S.A.Inventors: Norman Alan Greenberg, Kevin Burke Miller, Zamzam (Fariba) Kabiry Roughead
-
Publication number: 20120283180Abstract: This invention relates to a pea-based protein mixture and use thereof in a liquid nutritional composition, in particular suitable for tube feeding, and further relates to said liquid nutritional composition for providing long-term complete enteral nutrition to patients in need thereof. More specifically, the pea-based protein mixture and the liquid nutritional composition comprising said pea-based protein mixture comprises more than 25 weight % and up to 80 weight % of vegetable protein comprising a source of intact pea protein and a source of intact soy protein. The invention relates further to a method for long-term enteral nutrition of patients in need thereof comprising administering an effective amount of said liquid nutritional composition comprising said pea-based protein mixture, in particular comprising a defined amount of intact pea protein and a second vegetable intact protein, other than pea protein.Type: ApplicationFiled: April 27, 2010Publication date: November 8, 2012Applicant: N.V. NUTRICIAInventors: Zandrie Hofman, Rogier Daniël Van Anholt, Wynette Hermina Agnes Kiers, Thomas Ludwig, Claudia Catharina Maria Van Den Braak, Marianne Klebach
-
Publication number: 20120270777Abstract: The present invention relates generally to the field of neuronal health and neuronal protection. One embodiment of the present invention relates to a composition that can be used for the protection of the enteric nervous system from neurodegeneration. Disorders linked to an impaired enteric nervous system can be treated or prevented by the administration of lactoferrin containing compositions according to the present invention.Type: ApplicationFiled: May 7, 2010Publication date: October 25, 2012Applicant: NESTEC S.A.Inventors: Magali Faure, Bing Wang, Jeroen Schmitt
-
Publication number: 20120269868Abstract: Disclosed is a nutritional supplement composition including effective amounts of Coenzyme Q10, fish oil, vitamin D and a pharmaceutically acceptable excipient. Described is a method of promoting nutritional health comprising administering a nutritional supplement composition including Coenzyme Q10, fish oil, vitamin D and a pharmaceutically acceptable excipient to a subject. The nutritional supplement composition may further include flax seed oil, borage oil, evening primrose oil, vitamin E, resveratrol, vitamin B6, vitamin B12, folic acid, piperine and combinations. In some embodiments, administering Administering the nutritional supplement may ameliorate nutrient depletion, or promote cardiovascular health, liver health, or both. The nutritional supplement may be used to promote nutritional health taking a cholesterol lowering drug. The nutritional supplement may be used to ameliorate nutrient depletion taking a cholesterol lowering drug. The cholesterol lowering drug may be a statin.Type: ApplicationFiled: April 18, 2012Publication date: October 25, 2012Inventor: Paul Joseph FAERSTEIN
-
Publication number: 20120252723Abstract: The present invention is directed at a combination of (i) serine, (ii) cysteine, (iii) arginine and (iv) at least one branched amino acid, for use in the therapeutic or prophylactic treatment of inflammation or infection, wherein the combination is to be administered enterally and at a combination of (i) serine, (ii) cysteine, (iii) arginine and (iv) at least one branched amino acid, for use in the therapeutic or prophylactic treatment of an imbalance in the metabolic use of amino acid resources from the body or from nutrition in a subject having an inflammation or an infection, wherein the combination is to be administered enterally.Type: ApplicationFiled: August 23, 2010Publication date: October 4, 2012Applicant: N.V. NutriciaInventors: Klaske van Norren, Johannes Adrianus Cornelis Peters, Mirian Lansink
-
Publication number: 20120231999Abstract: Novel GLP-2 analogs with improved pharmacokinetic properties are described as well as their use in the treatment of disease.Type: ApplicationFiled: October 21, 2010Publication date: September 13, 2012Applicant: FERRING B.V.Inventors: Sudarkodi Alagarsamy, Guangcheng Jiang, Pierre Riviere, Claudio Daniel Schteingart, Javier Sueiras-Diaz
-
Patent number: 8252742Abstract: Methods for enhancing the quality of life of a senior or super senior animal by feeding the animal a composition comprising at least one omega-3 polyunsaturated fatty acid and various combinations of amino acids, minerals, and antioxidants in amounts effective to enhance alertness, improve vitality, protect cartilage, maintain muscle mass, enhance digestibility, and improve skin and pelage quality. Changes in expression of genes associated with several biological pathways induced in an animal by feeding it said composition are consistent with an enhanced quality of life.Type: GrantFiled: July 18, 2008Date of Patent: August 28, 2012Assignee: Hill's Pet Nutrition, Inc.Inventors: Ryan Michael Yamka, Kim Gene Friesen
-
Publication number: 20120190617Abstract: This invention relates to the use of niacin and/or trigonelline compounds to increase muscle weight during periods of activity or to inhibit muscle loss during periods of inactivity.Type: ApplicationFiled: June 10, 2010Publication date: July 26, 2012Inventors: Angelika Friedel, Karin Kuratli, Christof Wehrli, Karin Wertz, Swen Wolfram, Ying Wang-Schmidt
-
Publication number: 20120178674Abstract: Nutritional compositions with fucosyllactose and betagalactooligosaccharides for use in stimulation of the immune system. The composition is suitable for infants.Type: ApplicationFiled: July 12, 2010Publication date: July 12, 2012Inventors: Bernd Stahl, Alma Jildou Nauta, Johan Garssen, Eric Samain, Sophie Drouillard
-
Patent number: 8163278Abstract: A method of determining the efficacy of secretin, neuropeptides, peptides, and/or digestive enzymes for treatment of an individual diagnosed with a pervasive development disorder, such as autism, where the individual has an abnormal fecal chymotrypsin level and exhibits a lack of protein digestion. A sample of feces is obtained from the individual in order to determine a quantitative level of chymotrypsin in the sample. The quantitative level of chymotrypsin is used to determine the efficacy of treating the individual with secretin, neuropeptides, peptides, and/or digestive enzymes. If it is determined, based on the individual's fecal chymotrypsin level, that the individual would benefit from the administration of secretin, neuropeptides, peptides, and/or digestive enzymes, then the amount necessary to effect a change in the individual's autistic behavior is determined by the individual's fecal chymotrypsin level, age and weight.Type: GrantFiled: October 8, 2003Date of Patent: April 24, 2012Assignee: Curemark LLCInventor: Joan M. Fallon
-
Publication number: 20120094901Abstract: This invention relates to the coagulation of protein containing nutritional compositions in the upper gastro-intestinal tract, more in particular in the stomach and provides a method for reducing such coagulation.Type: ApplicationFiled: April 27, 2010Publication date: April 19, 2012Inventors: Thomas Ludwig, Claudia Catharina Mari van den Braak, Marianne Klebach, Zandrie Hofman
-
Patent number: 8142800Abstract: A practical high potency anti-craving oral medication or combined oral/IV drip medication is disclosed which comprises three components: a group of amino-acid substances, a group of vitamin substances, and a group of minerals, wherein each substance is selected for maximum efficacy in the body of an individual suffering from substance abuse disorder as opposed to the body of a healthy individual. The ingredients of the invention are selected to cooperate in easing metabolization in the bodies of individuals suffering the various medical conditions associated with substance abuse. The ingredients are provided orally to ease administration and to provide convenient use by patients: the oral medication may be a maintenance dosage or a corrective dosage.Type: GrantFiled: September 14, 2006Date of Patent: March 27, 2012Inventors: Tamea Rae Sisco, Keith Kenneth Skinner, Theodore Keller
-
Patent number: 8142799Abstract: A practical high potency anti-craving medication is disclosed which comprises three components: an amino-acid component, a vitamin component, and a mineral component, wherein each component is selected for maximum efficacy in the body of an individual suffering from substance abuse disorder as opposed to the body of a healthy individual. Additionally, the active agents are received by means of a prolonged administration, preferably by means of an IV drip, thus assuring a period of time in which the active agents are present in desired concentrations, and more preferably a prolonged time during which they are simultaneously present in desired concentrations. The agents of each component are also selected so as to allow easy administration of the medication to patients in three vials of medication rather than as a large number of individual vials.Type: GrantFiled: August 20, 2005Date of Patent: March 27, 2012Inventors: Tamea Rae Sisco, Keith Kenneth Skinner, Theodore R Keller
-
Publication number: 20120070487Abstract: The present invention provides nutraceutical compositions with enhanced oral bioavailability. The compositions of the present invention include one or more alkylsaccharides admixed with one or more nutraceutical.Type: ApplicationFiled: March 23, 2011Publication date: March 22, 2012Applicant: AEGIS THERAPEUTICS LLCInventor: Edward T. Maggio
-
Publication number: 20120040895Abstract: The present invention provides a process for producing a composition which is preferably a food, food intermediate, nutraceutical, dietary supplement, feed, or pet food, which comprises mixing together a peptide, preferably a bioactive peptide, and a dietary fibre. The composition of the invention can be used to improve the bioavailability of bioactive peptides or used as a food, food intermediate, nutraceutical, dietary supplement, feed, or pet food.Type: ApplicationFiled: October 15, 2009Publication date: February 16, 2012Inventors: Arie K. Kies, Pieter C. Pijl Van Der